SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-23-020720
Filing Date
2023-06-02
Accepted
2023-06-02 19:15:36
Documents
3
Period of Report
2023-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1685747726.html 4  
1 FORM 4 wk-form4_1685747726.xml 4 3335
2 EX-24 mrtx_-xsectionx16xpowerx.htm EX-24 3753
3 GRAPHIC mrtx_-xsectionx16xpowerx001.jpg GRAPHIC 204172
  Complete submission text file 0001628280-23-020720.txt   289717
Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address
Stelzer Laurie (Reporting) CIK: 0001644348 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 23990804